Pediatric prognostic models predicting inhospital child mortality in resource-limited settings: An external

Morris Ogero1,2, John Ndiritu1, Rachel Sarguta1

  • 1Department of Mathematics University of Nairobi Nairobi Kenya.

Health Science Reports
|August 30, 2023
PubMed

Insights

External validation of prognostic models like RISC-Malawi revealed they underestimate mortality risk. These models require recalibration for reliable use in new clinical settings.

Area of Science:

  • Clinical epidemiology
  • Biostatistics
  • Health outcomes research

Background:

  • Prognostic models aid clinical decisions but often lack external validation.
  • Uncertainty in reliability and generalizability hinders their widespread application.
  • This study addresses the need for external validation of existing models.

Purpose of the Study:

  • To externally validate four prognostic models, including the RISC-Malawi model.
  • To assess the transferability and clinical utility of these models in a new population.
  • To identify the need for model recalibration to improve generalizability.

Main Methods:

  • Utilized data from the Clinical Information Network (CIN) for external validation.
  • Included 163,329 eligible patients with in-hospital mortality as the primary outcome.
  • Assessed model performance using discrimination (AUC) and calibration (slope, intercept) after data imputation.

Main Results:

  • The RISC-Malawi model showed an AUC of 0.77, while Lowlavaar et al. models had an AUC of 0.75.
  • All validated models demonstrated calibration issues, markedly underestimating mortality risk.
  • Case-fatality rates were 8.7% for RISC-Malawi and 5.3% for Lowlavaar et al. models.

Conclusions:

  • Externally validated models showed significant underestimation of mortality risk.
  • Current models may not be reliable for use outside their original development contexts.
  • Recalibration is essential to enhance the generalizability and clinical applicability of these prognostic models.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
222
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96
Data Validation01:03

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
5.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
153
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178